Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Nederlands Tijdschrift Voor Geneeskunde|August 12, 2010
[Genetic variations affect drug safety and efficacy]Ankie M Harmsze, Vera H Deneer, Anke Hilse Maitland-van der Zee, et al.
European Journal of Clinical Pharmacology|April 19, 2011
Pharmacokinetics and protein binding of cefazolin in morbidly obese patientsSimone van Kralingen, Margot Taks, Jeroen Diepstraten, et al.
The Journal of Antimicrobial Chemotherapy|November 12, 2013
Reduced subcutaneous tissue distribution of cefazolin in morbidly obese versus non-obese patients determined using clinical microdialysisMargreke J E Brill, Aletta P I Houwink, Stephan Schmidt, et al.
Pharmacogenetics and Genomics|November 26, 2009
Besides CYP2C19*2, the variant allele CYP2C9*3 is associated with higher on-clopidogrel platelet reactivity in patients on dual antiplatelet therapy undergoing elective coronary stent implantationAnkie Harmsze, Jochem W van Werkum, Heleen J Bouman, et al.
JAMA|February 25, 2010
Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantationNicoline J Breet, Jochem W van Werkum, Heleen J Bouman, et al.
American Heart Journal|February 28, 2016
Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve ImplantationVincent Johan Nijenhuis, Naoual Bennaghmouch, Mariella Hassell, et al.
Pageof 1